Abiopharma

New Form 8-K - INDIVIOR PLC Filed: 2025-06-30 AccNo: 0001625297-25-000046 Size: 159 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

A New Press Release from Oncolytics Biotech, Inc

Moderna - Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine

Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy

AN2 Therapeutics Reports Key Insights from 200-Patient Observational Study in Acute Melioidosis, Laying Groundwork for Phase 2 Proof-of-Concept Trial of Epetraborole

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation

Iterum Names Christine Coyne as Chief Commercial Officer to LeadORLYNVAH™ Launch and Commercial Growth

New Form 8-K - ARVINAS, INC. Filed: 2025-06-30 AccNo: 0001655759-25-000128 Size: 157 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - Aclaris Therapeutics, Inc. Filed: 2025-06-30 AccNo: 0001558370-25-008984 Size: 5 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy

Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13

Protalix BioTherapeutics Added to Russell3000® and 2000 Indexes®

New Form 8-K - Vicarious Surgical Inc. Filed: 2025-06-30 AccNo: 0001213900-25-059237 Size: 615 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure …